Drugs / Polio Boost Immunization
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05077137 | Sep 2021 → Jul 2027 expected | melanoma | Duke University | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polio Boost Immunization | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05077137 ↗ |
| Modality | Vaccine | “The IPOL vaccine is administered as 0.5 mL intramuscular or subcutaneous injection in the extremity (thigh or upper arm) in closest proximity to the largest tumor” NCT05077137 ↗ |
| Route | Intramuscular | “administered as 0.5 mL intramuscular or subcutaneous injection” NCT05077137 ↗ |
| Route | Subcutaneous | “administered as 0.5 mL intramuscular or subcutaneous injection” NCT05077137 ↗ |